0001415889-24-007367.txt : 20240308
0001415889-24-007367.hdr.sgml : 20240308
20240308165241
ACCESSION NUMBER: 0001415889-24-007367
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETERS WILLIAM J
CENTRAL INDEX KEY: 0001263136
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 24735226
MAIL ADDRESS:
STREET 1: C/O AMPHASTAR PHARMACEUTICALS, INC.
STREET 2: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
form4-03082024_090331.xml
X0508
4
2024-03-06
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001263136
PETERS WILLIAM J
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
true
true
false
false
CFO, EVP & TREASURER
1
Common Stock
2024-03-06
4
M
0
8826
11.33
A
129626
D
Common Stock
2024-03-06
4
S
0
13404
46.2951
D
116222
D
Common Stock
2024-03-06
4
S
0
4681
46.9762
D
111541
D
Common Stock
2024-03-06
4
S
0
51
48
D
111490
D
Common Stock
2024-03-06
4
F
0
2190
46.31
D
109300
D
Employee Stock Option (right to buy)
11.33
2024-03-06
4
M
0
8826
0
D
2026-03-17
Common Stock
8826
0
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.79 to $46.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.795 to $47.47, inclusive.
The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
Shares subject to the option are fully vested and immediately exercisable.
/s/ William J. Peters
2024-03-08